Donald Hayden

Donald Hayden

Verkställande Direktör på
WindMIL Therapeutics, Inc.
70 år
Health Technology
Consumer Services
Consumer Non-Durables

Profil

Donald J.
Hayden
is currently the Chairman & Chief Executive Officer at WindMIL Therapeutics, Inc. He is also the Chairman at Avanir Pharmaceuticals, Inc. and Otsuka America Pharmaceutical, Inc. Previously, he held various Chairman positions at Azelon Pharmaceuticals, Inc., Gloucester Pharmaceuticals, Inc., Satori Pharmaceuticals, Inc., Alvine Pharmaceuticals, Inc., REGENXBIO, Inc., Vitae Pharmaceuticals LLC, Transave, Inc., Insmed Ltd., Amicus Therapeutics, Inc., Cogentus Pharmaceuticals, Inc., Otsuka America Pharmaceutical, Inc., Nora Therapeutics, Inc., and Dimension Therapeutics, Inc. He was also the Executive VP & President-Americas Region at Bristol Myers Squibb Co. and Vice President & GM-Mead Johnson Laboratories at Mead Johnson Nutrition Co. Additionally, he served as a Senior Advisor at Prospect Venture Partners.
He received his undergraduate degree from Harvard University and his MBA from Indiana University.

Aktiva positioner av Donald Hayden

FöretagPositionStart
Verkställande Direktör 2019-04-25
Ordförande -

Tidigare kända positioner av Donald Hayden

FöretagPositionSlut
THESEUS PHARMACEUTICALS, INC. Direktör/Styrelseledamot 2024-02-14
REGENXBIO INC. Ordförande 2020-07-01
INSMED INCORPORATED Ordförande 2018-11-08
AMICUS THERAPEUTICS, INC. Ordförande 2010-02-08
VITAE PHARMACEUTICALS INC Ordförande 2016-10-25
Se detaljerna i Donald Haydens erfarenhet

Donald Haydens utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

80

Första gradens relationer

23

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag23

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Non-Durables

Health Technology

Consumer Services

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Donald Hayden